王继伟, 姜庆五. “新型冠状病毒肺炎”更名为“新型冠状病毒感染症”的思考[J]. 上海预防医学, 2022, 34(8): 725-727. DOI: 10.19428/j.cnki.sjpm.2022.22029
引用本文: 王继伟, 姜庆五. “新型冠状病毒肺炎”更名为“新型冠状病毒感染症”的思考[J]. 上海预防医学, 2022, 34(8): 725-727. DOI: 10.19428/j.cnki.sjpm.2022.22029
WANG Jiwei, JIANG Qingwu. Thoughts on renamingCoronavirus disease 2019toCoronavirus infectious syndrome 2019”[J]. Shanghai Journal of Preventive Medicine, 2022, 34(8): 725-727. DOI: 10.19428/j.cnki.sjpm.2022.22029
Citation: WANG Jiwei, JIANG Qingwu. Thoughts on renamingCoronavirus disease 2019toCoronavirus infectious syndrome 2019”[J]. Shanghai Journal of Preventive Medicine, 2022, 34(8): 725-727. DOI: 10.19428/j.cnki.sjpm.2022.22029

“新型冠状病毒肺炎”更名为“新型冠状病毒感染症”的思考

Thoughts on renamingCoronavirus disease 2019toCoronavirus infectious syndrome 2019

  • 摘要: 介绍新型冠状病毒野生株、Delta变异株和Omicron变异株各自的流行特征及临床表现,阐明目前新型冠状病毒的传播力、致病力和毒力所发生的变化以及患者临床表现的改变,并在此基础上提出将“新型冠状病毒肺炎”更名为“新型冠状病毒感染症”的原因和意义。

     

    Abstract: This paper introduces the respective epidemiological characteristics and clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including the wild-type strain, Delta variant and Omicron variant. It clarifies the current transmissibility, pathogenicity and virulence changes of the SARS-CoV-2, as well as the change in the clinical manifestations of patients. On this basis, this paper proposes the reasons and significance of changing the name of "Coronavirus Disease 2019" to " Coronavirus Infectious Syndrome 2019".

     

/

返回文章
返回